Zoetis inc stock.

Zoetis Inc. : Forcasts, revenue, earnings, analysts expectations, ratios for Zoetis Inc. Stock | ZTS | US98978V1035The company reported revenue of $2.0 billion for the third quarter of 2022, an increase of 1% compared with the third quarter of 2021. Net income for the third quarter of 2022 was $529 million, or $1.13 per diluted share, a decrease of 4% and 3%, respectively, on a reported basis. On an operational 1 basis, revenue for the third quarter of 2022 ...The estimated Net Worth of William C Jr Steere is at least $6.34 millió dollars as of 20 May 2021. Mr. Steere owns over 16,170 units of Zoetis Inc stock worth over $6,013,788 and over the last 20 years he sold ZTS stock worth over $0. In addition, he makes $330,000 as Independent Director at Zoetis Inc.Zoetis is a component of the S&P 500 and has roughly 13,800 employees. Analyst Report: Zoetis Inc Zoetis Inc., a 2013 spinoff from Pfizer, focuses on the development, manufacture and ...Get the latest Zoetis Inc (ZOE) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

View Zoetis Inc ZTS investment & stock information. Get the latest Zoetis Inc ZTS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Find the latest Zoetis Inc. (ZTS) stock quote, history, news and other vital information to help you with your stock trading and investing.

See the latest Zoetis Inc Class A stock price (ZTS:XNYS), related news, valuation, dividends and more to help you make your investing decisions.ZOETIS INC is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 77% based on the firm’s underlying …At Zoetis, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.Analyst Sentiment - World. United States Canada UK Hong Kong Japan Australia New Zealand. Germany Switzerland Spain Poland Netherlands Greece France Ireland Italy Belgium Austria Israel Türkiye

Sandra has made over 1 trades of the Zoetis Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently Sandra bought 2,000 units of ZTS stock worth $52,000 on 6 February 2013.

US98978V1035. Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments.

Zoetis Inc. (ZTS) Outperforms Peers and Shows Promising Growth: A Strong Buy Recommendation November 3, 2023TipRanks. Zoetis price target lowered to $255 from $260 at Barclays November 3 ...The estimated Net Worth of Paul Bisaro is at least $38.1 millió dollars as of 14 March 2023. Mr. Bisaro owns over 5,000 units of Zoetis Inc stock worth over $13,738,448 and over the last 10 years he sold ZTS stock worth over $24,032,600. In addition, he makes $355,000 as Independent Director at Zoetis Inc.The estimated Net Worth of Paul Bisaro is at least $38.1 Million dollars as of 14 March 2023. Mr. Bisaro owns over 5,000 units of Zoetis Inc stock worth over $13,665,873 and over the last 10 years he sold ZTS stock worth over $24,032,600. In addition, he makes $355,000 as Independent Director at Zoetis Inc.Mar 1, 2023 · Headquartered in Parsippany, New Jersey, Zoetis Inc. (NYSE:ZTS) is an animal health medicines, vaccines, and diagnostic products manufacturer. On February 28, 2023, Zoetis Inc. (NYSE:ZTS) stock ... Zoetis Announces First Quarter 2022 Results. Reports Revenue of $2.0 Billion, Growing 6%, and Net Income of $595 Million, or $1.26 per Diluted Share, Increasing 6% and 8%, Respectively, on a Reported Basis for First Quarter 2022. Delivers 9% Operational Growth in Revenue and 8% Operational Growth in Adjusted Net Income for First Quarter 2022.In the previous week, Boston Scientific had 6 more articles in the media than Zoetis. MarketBeat recorded 12 mentions for Boston Scientific and 6 mentions for Zoetis. Boston Scientific's average media sentiment score of 1.32 beat Zoetis' score of 0.64 indicating that Zoetis is being referred to more favorably in the news media.The Dividend Yield % of Zoetis Inc (ZTS) is 0.84% (As of Today), Highest Dividend Payout Ratio of Zoetis Inc (ZTS) was 0.3. The lowest was 0.16. And the median was 0.19. The Forward Dividend Yield % of Zoetis Inc (ZTS) is 0.84%. For more information regarding to dividend, please check our Dividend Page .

Back to ZTS Overview. The Dividend History page provides a single page to review all of the aggregated Dividend payment information. Visit our Dividend Calendar: Our partner, Quotemedia, provides ...Hayward Pool Products Inc is a leading manufacturer of high-quality pool equipment, including pumps, filters, heaters, and cleaners. If you’re lucky enough to own one of their products, it’s important to keep it in good condition to ensure ...Discover historical prices for T stock on Yahoo Finance. View daily, weekly or monthly format back to when AT&T Inc. stock was issued.Willie Reed ZTS stock SEC Form 4 insiders trading. Willie has made over 9 trades of the Zoetis Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 1,626 units of ZTS stock worth $280,729 on 11 February 2023.. The largest trade he's ever made was exercising 3,704 units of Zoetis Inc stock on 14 …We reiterate our Buy rating on Zoetis Inc. stock. While its forecasted annualized return by 2025 year-end is below 10%, this is a resilient business with strong long-term growth potential, ...Zoetis Inc. (ZTS Quick Quote ZTS - Free Report) reported first-quarter 2023 adjusted earnings (excluding one-time items) of $1.31 per share, which beat the Zacks Consensus Estimate and our model ...

294.88M. 64.05%. Get the latest Zoetis Inc (ZTS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

The stock price of Zoetis, an animal health company, has seen a 9% fall in a month, while it is down 6% in a week. The company reported upbeat Q4 results last month, with revenue of $2.0 billion ...Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.Zoetis Inc - Class A (ZTS) stock price prediction is 338.41269225246 USD. The Zoetis Inc - Class A stock forecast is 338.41269225246 USD for 2024 November ...Dec 1, 2023 · Zoetis Inc. is an animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health technology. In 2011, Zoetis Inc.’s revenues exceeded $4.2 billion and $4.34 billion in 2012. The animal health industry worldwide is an estimated US$22 billion dollar industry. IPO. Records show that Pfizer officially filled for registration of a Class A stock with the U.S. Securities and Exchange Commission on August 10, 2012.Dec 1, 2023 · Analyst Forecast. According to 6 analysts, the average rating for ZTS stock is "Strong Buy." The 12-month stock price forecast is $223.0, which is an increase of 24.27% from the latest price. The largest individual shareholder of Apple, Inc. is Arthur D. Levinson, with over 1.1 million shares, as of late November 2014. Levinson is currently the non-executive Chairman of the Board of directors for Apple. He joined the Board in 20...For the Zoetis Inc forecast (traded under symbol ZTS) ... Zoetis Inc: Stock buyback: ZTS buyback: Website: www.zoetis.com: Sector: Drugs & Pharmaceuticals: Number of ETFs Holding ZTS: 100 (see which ones) Total Market Value Held by ETFs: $9,326,985,263.3: Total Market Capitalization:

Zoetis may alter or terminate the terms of the FP Guarantee at any time and for any reason. GBF-00659. Beef news & updates. August 3, 2022. Press Release Zoetis Recieves Expanded Labels For Beef Implant Products. August 29, 2022. Press Release Zoetis Continues Support of Folds of Honor Mission With Donation.

Nov 30, 2023 · Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock. Is Zoetis Inc worth watching? 12 stock analysts on Stockchase covered Zoetis Inc In the last year. It is a trending stock that is worth watching. What is Zoetis Inc ...

Alejandro has made over 1 trades of the Zoetis Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently Alejandro sold 69,640 units of ZTS stock worth $5,651,982 on 21 February 2018.Complete Zoetis Inc. stock information by Barron's. View real-time ZTS stock price and news, along with industry-best analysis. Apr 6, 2023 · Zoetis Inc. (NYSE: ZTS) is a company that has got both marketing and innovation right in the last decade, which has led to a 4-fold growth in net income since 2013. The company has continued to ... Zoetis Inc. ZTS delivered second-quarter 2023 adjusted earnings (excluding one-time items) of $1.41 per share, which beat the Zacks Consensus Estimate of $1.32 per share.In the year-ago quarter ...Zoetis Declares Fourth Quarter 2022 Dividend. October 13, 2022. PARSIPPANY, N.J.-- (BUSINESS WIRE)-- The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.325 per share for the fourth quarter of 2022. The dividend will be paid on Thursday, December 1, 2022, to all holders of record of the Company’s common stock as of ...Zoetis Declares Fourth Quarter 2023 Dividend October 12, 2023. Zoetis Named a 100 Best Company for Working Parents by Seramount October 10, 2023. Zoetis to Host Webcast and Conference Call on Third Quarter 2023 Financial Results September 27, 2023. Zoetis Foundation Announces $2.6 Million in Grants to Advance Opportunities for …As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After 70+ years of innovating ways to predict, prevent, detect and treat animal illness, Zoetis continues to stand by those raising and caring for animals worldwide — from livestock farmers to …Zoetis Inc. Class A Common Stock (ZTS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Zoetis Completes Acquisition of Nexvet Biopharma. July 31, 2017. Acquisition strengthens pipeline of companion animal therapeutics for chronic pain, a global market estimated at US$400 million annually 1. Purchase price of US$6.72 per share, or approximately US$85 million in aggregate. Zoetis Inc. (NYSE:ZTS) and Nexvet …Find the latest Zoetis Inc. (ZTS) stock quote, history, news and other vital information to help you with your stock trading and investing.Zoetis Inc. (ZTS) Outperforms Peers and Shows Promising Growth: A Strong Buy Recommendation November 3, 2023TipRanks. Zoetis price target lowered to $255 from $260 at Barclays November 3 ... Financial Performance: Zoetis Inc has shown a strong financial performance with a steady increase in revenue and net income. The company's revenue increased by 5% from $6,040 million in the first ...Instagram:https://instagram. tmj botox covered by insurancebad news today23andme company stockoptions for beginners Zoetis Inc. (ZTS.NYSE) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Zoetis Inc. | Nyse: ZTS | Nyse how to flip sneakersjandj dividend The stock price of Zoetis, an animal health company, has seen a 9% fall in a month, while it is down 6% in a week. The company reported upbeat Q4 results last month, with revenue of $2.0 billion ... td ameritrade forex spreads At Zoetis, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.Zoetis Inc. (NYSE:ZTS) today announced that its Board of Directors has authorized a $1.5 billion multi-year share repurchase program as part of its long-term capital allocation plans. The shares are expected to be repurchased at the discretion of management over a multi-year period, and the program can be cancelled at any time.Lbp Am Sa cut its stake in Zoetis Inc. (NYSE:ZTS - Free Report) by 23.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC).The firm owned 129,342 shares of the company's stock after selling 40,018 shares during the period. Lbp Am Sa's holdings in Zoetis were worth …